Townsend Richard Nolan 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Townsend Richard Nolan（CIK 1995218）在 1 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-09-28）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-28 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 买入 | 2,306 | $6,097 |
| 2026-08-19 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 3,345 | $16,562 |
| 2026-07-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 买入 | 67,000 | $0 |
| 2026-07-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 25,947 | $116,243 |
| 2026-05-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 3,342 | $16,911 |
| 2026-04-07 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 55,000 | $312,950 |
| 2026-03-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 买入 | 2,623 | $6,925 |
| 2026-02-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 10,173 | $64,904 |
| 2026-02-06 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 买入 | 161,665 | $0 |
| 2025-11-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 1,127 | $10,447 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 买入 | 33,000 | $0 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 12,985 | $116,086 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 148 | $1,415 |
| 2025-09-16 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 买入 | 2,193 | $5,790 |
| 2025-09-10 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 1,115 | $5,207 |
| 2025-08-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 2,735 | $12,772 |
| 2025-05-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | 卖出 | 1,074 | $2,975 |
来源：SEC Form 4 申报文件 · 截至 2026-09-28